{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:07:25Z","timestamp":1758931645029,"version":"3.44.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["NIHR127385"],"award-info":[{"award-number":["NIHR127385"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Orthostatic hypotension (OH) is a common debilitating condition characterised by a significant drop in blood pressure (BP) on standing upright. Adults with OH are typically offered non-pharmacologic therapies, either alone or in combination with medication. The two most used agents are fludrocortisone and midodrine. There is a lack of good quality evidence for any of these treatments, all of which are in widespread clinical use. The aim of this internal pilot trial was to evaluate recruitment, attrition, treatment crossover and quality of outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The trial was designed as a pragmatic, open-label, randomised, prospective, multicentre, superior and multi-arm internal pilot. Recruitment was for 10 months, during which we aimed to open 14 sites and recruit a target of 64 adults with OH to evaluate feasibility of recruitment. Attrition, crossover and data collection were also assessed. Participants were randomised to one of three treatments: nondrug therapies (control), fludrocortisone plus nondrug therapies or midodrine plus nondrug therapies. Outcomes measured included symptoms, quality of life, activities of daily living, postural BP, use of health and care services, falls and safety. Participants received treatment and were followed up for 12 months. Pre-planned criteria to progress from internal pilot were defined for recruitment, retention, crossover and outcome completion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Between the 3rd December 2021 and 31st August 2022, 13 participants were randomised from 4 of 9 recruiting centres. Redeployment of clinical and research staff, due to COVID-19, limited the number of available sites. Participants already receiving fludrocortisone or midodrine accounted for 120 of 233 eligible participants being excluded. Due to the low sample size, the rates of attrition and crossover are of limited value. Apart from the falls diaries, completion rates of the outcome measures were high (&gt;\u200980%). Due to low recruitment rates, the pilot did not progress to the planned multi-arm multistage trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In its current design, this trial was not feasible. The main barriers to success were participants already receiving treatment and redeployment of clinical and academic staff during and after the COVID-19 pandemic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ISRCTN 87213295, 23 July 2021,  <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN87213295\" ext-link-type=\"uri\">https:\/\/www.isrctn.com\/ISRCTN87213295<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40814-025-01704-7","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:34:12Z","timestamp":1758882852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): results from an internal pilot randomised controlled trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Helen","family":"Mossop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Al-Ashmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tumi","family":"Sotire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles D.","family":"Witham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Phillipson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M. S.","family":"Wason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison J.","family":"Yarnall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose Anne","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-3701","authenticated-orcid":false,"given":"James","family":"Frith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"2","key":"1704_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69\u201372.","journal-title":"Clin Auton Res"},{"issue":"36","key":"1704_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008004","volume":"96","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Ke SJ, Qiu XP, Liu LB. Prevalence, risk factors, and prognosis of orthostatic hypotension in diabetic patients: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(36):e8004.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"1704_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","volume":"17","author":"DC Velseboer","year":"2011","unstructured":"Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM. Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011;17(10):724\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"1704_CR4","doi-asserted-by":"crossref","unstructured":"Saedon NIz, Tan MP, Frith J. The prevalence of orthostatic hypotension: a systematic review and meta-analysis. The Journals of Gerontology: Series A 2018:gly188-gly188.","DOI":"10.1093\/gerona\/gly188"},{"key":"1704_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2017.11.344","volume":"47","author":"A Merola","year":"2018","unstructured":"Merola A, Sawyer RP, Artusi CA, Suri R, Berndt Z, Lopez-Castellanos JR, et al. Orthostatic hypotension in Parkinson disease: impact on health care utilization. Parkinsonism Relat Disord. 2018;47:45\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1704_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","volume":"22","author":"H Kaufmann","year":"2012","unstructured":"Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. The orthostatic hypotension questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res. 2012;22(2):79\u201390.","journal-title":"Clin Auton Res"},{"key":"1704_CR7","doi-asserted-by":"crossref","unstructured":"McDonald C, Pearce M, Kerr SR, Newton J. A prospective study of the association between orthostatic hypotension and falls: definition matters. Age Ageing 2016.","DOI":"10.1093\/ageing\/afw227"},{"issue":"1","key":"1704_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11136-019-02295-6","volume":"29","author":"N Kim","year":"2020","unstructured":"Kim N, Park J, Hong H, Kong ID, Kang H. Orthostatic hypotension and health-related quality of life among community-living older people in Korea. Qual Life Res. 2020;29(1):303\u201312.","journal-title":"Qual Life Res"},{"issue":"8","key":"1704_CR9","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/HJH.0000000000000235","volume":"32","author":"A Angelousi","year":"2014","unstructured":"Angelousi A, Girerd N, Benetos A, Frimat L, Gautier S, Weryha G, et al. Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis. J Hypertens. 2014;32(8):1562\u201371.","journal-title":"J Hypertens"},{"issue":"25","key":"1704_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/eurheartj\/ehv093","volume":"36","author":"F Ricci","year":"2015","unstructured":"Ricci F, Fedorowski A, Radico F, Romanello M, Tatasciore A, Di Nicola M, et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J. 2015;36(25):1609\u201317.","journal-title":"Eur Heart J"},{"issue":"2","key":"1704_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/ageing\/aft213","volume":"46","author":"J Frith","year":"2017","unstructured":"Frith J, Parry SW. New horizons in orthostatic hypotension. Age Ageing. 2017;46(2):168\u201374.","journal-title":"Age Ageing"},{"key":"1704_CR12","unstructured":"NICE [ESUOM20]: Postural hypotension in adults: fludrocortisone. NICE Evidence summary 2013."},{"key":"1704_CR13","unstructured":"NICE [ESNM61]: Orthostatic hypotension due to autonomic dysfunction: midodrine. NICE Evidence summary 2015."},{"issue":"21","key":"1704_CR14","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","volume":"39","author":"M Brignole","year":"2018","unstructured":"Brignole M, Moya A, de Lange FJ, Deharo J-C, Elliott PM, Fanciulli A, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883\u2013948.","journal-title":"Eur Heart J"},{"issue":"5","key":"1704_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ageing\/afs061","volume":"41","author":"IC Logan","year":"2012","unstructured":"Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012;41(5):587\u201394.","journal-title":"Age Ageing"},{"key":"1704_CR16","doi-asserted-by":"crossref","unstructured":"Mills PB, Fung CK, Travlos A, Krassioukov A. Nonpharmacologic management of orthostatic hypotension: a systematic review. Arch Phys Med Rehabil 2015;96(2):366\u2013375 e366.","DOI":"10.1016\/j.apmr.2014.09.028"},{"issue":"7","key":"1704_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/ijcp.12122","volume":"67","author":"AC Ong","year":"2013","unstructured":"Ong AC, Myint PK, Shepstone L, Potter JF. A systematic review of the pharmacological management of orthostatic hypotension. Int J Clin Pract. 2013;67(7):633\u201346.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"1704_CR18","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s11606-013-2520-3","volume":"28","author":"AK Parsaik","year":"2013","unstructured":"Parsaik AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, et al. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013;28(11):1496\u2013503.","journal-title":"J Gen Intern Med"},{"key":"1704_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac153","author":"JR Gibbon","year":"2022","unstructured":"Gibbon JR, Parry SW, Witham MD, Yarnall A, Frith J. Feasibility, reliability and safety of self-assessed orthostatic blood pressure at home. Age Ageing. 2022. https:\/\/doi.org\/10.1093\/ageing\/afac153.","journal-title":"Age Ageing"},{"issue":"4","key":"1704_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/026921558700100409","volume":"1","author":"FM Nouri","year":"1987","unstructured":"Nouri FM, Lincoln NB. An extended activities of daily living scale for stroke patients. Clin Rehabil. 1987;1(4):301\u20135.","journal-title":"Clin Rehabil"},{"issue":"6","key":"1704_CR21","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S1473-3099(20)30791-X","volume":"21","author":"AS Walker","year":"2021","unstructured":"Walker AS, White IR, Turner RM, Hsu LY, Yeo TW, White NJ, et al. Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infections. Lancet Infect Dis. 2021;21(6):e175\u201381.","journal-title":"Lancet Infect Dis"},{"issue":"726","key":"1704_CR22","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.3399\/BJGP.2022.0111","volume":"73","author":"C Bhanu","year":"2023","unstructured":"Bhanu C, Petersen I, Orlu M, Davis D, Walters K. Incidence of postural hypotension recorded in UK general practice: an electronic health records study. Br J Gen Pract. 2023;73(726):e9\u201315.","journal-title":"Br J Gen Pract"},{"issue":"19","key":"1704_CR23","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1056\/NEJMoa2001500","volume":"383","author":"SE Lamb","year":"2020","unstructured":"Lamb SE, Bruce J, Hossain A, Ji C, Longo R, Lall R, et al. Screening and intervention to prevent falls and fractures in older people. N Engl J Med. 2020;383(19):1848\u201359.","journal-title":"N Engl J Med"},{"key":"1704_CR24","doi-asserted-by":"crossref","unstructured":"Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE. Interventions for preventing falls in older people living in the community.\u00a0Cochrane Database Syst Rev.\u00a02012;9:CD007146.","DOI":"10.1002\/14651858.CD007146.pub3"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-025-01704-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:34:14Z","timestamp":1758882854000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-025-01704-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1704"],"URL":"https:\/\/doi.org\/10.1186\/s40814-025-01704-7","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided fully informed, written consent. The study was approved by the UK NHS Health Research Authority\u2019s Newcastle & North Tyneside 1 Research Ethics Committee (reference 21\/NE\/0083).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}